新規な糖代謝経路で働く酵素の構造生物学的研究 by 南 煐祐 & YOUNG WOO NAM
  
 
博士論文 
 
 
Studies on structures of novel sugar metabolic enzymes 
(新規な糖代謝経路で働く酵素の構造生物学的研究) 
 
 
 
 
 
 
 
 
 
 
 
 
平成 24年進学  南
ナム
 煐
ヨン
祐
ウ
 
指導教員  伏信進矢
  
Index 
 
Abbreviations .......................................................................................................................................... 1 
Chapter 1 General Introduction............................................................................................................... 1 
1-1 Sugar metabolic pathways in microbes ................................................................................. 2 
1-1-1 Cellulose degradation enzymes in fungi .................................................................... 3 
1-1-2 Enzymes in Leloir pathway........................................................................................ 4 
1-2 Novel sugar metabolic pathways .......................................................................................... 6 
1-2-1 Intracellular degradation pathway in microbes that is linked to oxidative cellulose 
degradation .............................................................................................................................. 6 
1-2-2 Intracellular GNB/LNB pathway in Bifidobacterium longum ...................................... 8 
1-3 The aim of this thesis .......................................................................................................... 12 
1-4 References .............................................................................................................................. 13 
Chapter 2 X-ray crystallography of cellobionic acid phosphorylase from S. degradans 2-40 ............. 18 
Chapter 3 X-ray crystallography of UDP- glucose hexose 1-uridylytransferase and UDP-galactose 4-
epimerase in GNB/LNB pathway ......................................................................................................... 19 
3-1 Introduction ............................................................................................................................ 20 
3-2 Materials and Methods ........................................................................................................... 22 
3-2-1 Protein expression check ............................................................................................. 22 
3-2-2 Protein Preparation ...................................................................................................... 22 
3-2-3 Crystallization ............................................................................................................. 23 
3-2-4 Data collection ............................................................................................................. 24 
3-2-5 Phase calculation of bGalT .......................................................................................... 24 
3-2-6 Molecular replacement and Refinement of bGalE ...................................................... 24 
3-3 Results .................................................................................................................................... 25 
3-3-1 Crystallization and data collection of bGalT and bGalE ............................................. 25 
3-3-2 Overall structure of bGalE .......................................................................................... 27 
3-3-3 NAD+ binding site ....................................................................................................... 30 
3-3-4 UDP-hexose binding site ............................................................................................. 31 
3-3-5 Structural basis for substrate specificity in bGalE ...................................................... 34 
3-4 Discussion ............................................................................................................................... 36 
  
3-5 References .............................................................................................................................. 43 
Chapter 4 Concluding Remarks ............................................................................................................ 47 
Acknowledgments ......................................................................................................................... 51 
  
 
Abbreviations 
 
AA   Auxiliary Activities 
bGalE   UDP-galactose 4'-epimerase from bifidobacterium longum 
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Chapter 1 General Introduction 
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1-1  Sugar metabolic pathways in microbes 
In biochemistry, sugar metabolic pathways are series of chemical reactions related to extra- and intra-
cellular enzymes in organisms. The sugar metabolic pathways play important roles as the maintenance 
of homeostasis and the creation of new biomolecules by catabolism and anabolism. In all organisms, 
the metabolic pathways are linked as metabolic networks. Glycolysis, one of the most well-known sugar 
metabolic pathways in all aerobic and anaerobic organisms, also links to both Leloir pathway (galactose 
degradation) and cellulose degradation pathway. In these linked pathways, glucose-6-phosphate 
produced by last step of Leloir pathway and glucose produced by the cellulose degradation pathway 
can be utilized in glycolysis for generating energy (Fig. 1-1). Both intracellular pathways, glycolysis 
and Leloir pathway, consist of several enzymes acting as dehydrogenases, transferases, isomeraes, or 
epimerases. Each enzyme has been characterized and analyzed to understand reaction mechanisms in 
the pathways though the investigation of functional and structural properties. 
In addition, the discovery of novel enzymes drives advances in understanding new sugar metabolic 
pathways in organisms. The enzymes in the new sugar metabolic pathways would catalyze specific 
reactions that involve specific substrates. It is possible that the research is more progressing, the 
metabolic networks can be more complicated. 
 
Fig. 1-1 Shematic representation of sugar metabolisms linked to glycolysis. (A) Leloir 
pathway and (B) Cellulose degradation pathway 
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1-1-1 Cellulose degradation enzymes in fungi 
 Cellulose is a linear polysaccharide that constitutes plant cell wall (about 50%) as well as the most 
abundant organic compound in nature. Cellulose consists of β-1,4-linked D-glucopyranosides which 
form long biopolymer chains. Studies for enzymatic degradation of cellulose have been expected to 
play a critical role in applications for biofuels and chemicals when considering the production of 
renewable resources in the future.  
 The cellulases are wildly found in organisms such as fungi, bacteria, and actinomycetes. Cellulases are 
often composed of a catalytic domain and one or more carbohydrate-binding modules (CBMs), 
previously named carbohydrate-binding or cellulose-binding domains (1, 2). A cellulose degradation 
system in fugi typically consists of three enzymes: cellobiohydrolase (CBH, EC3.2.1.91), 
endoglucanase (EG, EC 3.2.1.4), and β-glucosidase (BGL, EC 3.2.1.21), as shown in Fig. 1-2. The 
cellobiohydrolases liberate disaccharide cellbiose from the ends of exposed cellulose polysaccharide 
while the endoglucanases cleave β-1,4 glycosidic bonds within the cellulose polymer chains (3). 
Moreover, β-glucosidases catalyze the hydrolysis of the β-glucosidic linkage with release of 
monosaccharide glucose (4, 5). Additionally, cellobiose produced by the CBH is oxidized by the major 
oxidoreductase, cellobiose dehydrogenase (CDH, EC 1.1.99.18), producing cellobiono-1,5-lactone. 
The lactone is hydrolyzed spontaneously in solution to generate cellobionic acid (6, 7). Although this 
concept is typically accepted, it still remains difficult to understand how the glycoside hydrolases could 
act on crystalline polysaccharide chains. 
 The previously classified enzymes as GH61 in the CAZy database of carbohydrate-active enzymes 
were unknown for hydrolytic activity. The first obtained structure of GH61 was not able to explain the 
catalytic mechanism, because the carboxylate groups containing amino acid residues (Asp or Glu) were 
missing (8). However, the genome, transcriptome, proteomic and structural analyses of cellulolytic 
fungi have identified it as an oxidative enzyme (9-11). The GH61 protein structures have a conserved 
arrangement of the N-terminal amino group and two histidines which coordinate a copper ion (12, 13). 
Finally, the functions of these enzyme were revealed as lytic polysaccharide monooxigenases (LPMOs) 
and led to a reclassification in the CAZy database from GH61 to “Auxiliary Activity (AA)” family 9 
(Table 1-1) (14). In fungi, copper-dependent LPMOs have been shown to catalyze the oxidative 
cleavage of glycosidic bonds on the surface of cellulose without requiring separation of a glucan chain 
and increase the substrate accessibility for hydrolytic enzymes such as CBHs, and EGs (15). Thus, 
LPMOs create an entry clefts for GHs, with the hydroxylation of the C1 position of pyranose, an 
aldonolactone. 
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Table 1-1 Classification of structure-known LPMOs. 
Organisms Protein Name Family PDB 
Fungi Hypcrea jecorina  GH61B AA9 2VTC 
Thielavia terrestris  GH61E AA9 3EII, 3EJA 
Thermoaucus aurantiacus  GH61A AA9 2YET, 3ZUD 
Neurospora crassa  PMO-2, PMO-3 AA9 4EIR, 4EIS 
Bacteria Serratia marcescens  CBP21 AA10 2LHS, 2BEM, 2BEN 
Vibrio cholera  CBM33 AA10 2XWX 
Enterococcus faecalis CBM33 AA10 4A02, 4ALC[E,O,R,S,T] 
Burkholderia pseudomallei CBM33 AA10 3UAM 
 
1-1-2 Enzymes in Leloir pathway 
 Galactose is an essential component of glycoproteins and glycolipids in metazoans and a constituent 
of the milk sugar, lactose for mammalian infants as a key nutrient. The main pathway of galactose 
metabolism is the Leloir pathway which was found by Dr. Luis Leloir and was named after the Nobel 
Prize-winning in part for his contribution to the understanding of galactose metabolism (16). The 
pathway requires five enzymes to sequentially convert galactose into glucose 6-phosphate (Fig. 1-2). In 
the reactions of Leloir pathway, the initial step is the conversion of β-D-galactose to α-D-galactose by 
galactose mutarotase (GalM, EC 5.1.3.3) since this is the active state in this pathway. Next, 
galactokinase (GalK, EC 2.7.1.6) phosphorylates α-D-galactose to form galactose-1-phosphate. In the 
third step, galactose-1-phosphate uridylyltransferase (GalT, EC 2.7.7.12) transfers uridine 
monophosphate from uridine diphosphoglucose to galactose-1-phosphate which is catalyzed by 
phosphoglucomutase (EC 5.4.2.2) and then linked to the glycolytic pathway. Finally, UDP-galactose 4-
epimerase (GalE, EC 5.1.3.2) interconverts UDP-galactose to UDP-glucose.  
The GalE enzyme from E. coli generally interconverts UDP-galactose to UDP-glucose whereas the 
human GalE enzyme interconverts both UDP-galactose and UDP-N-acetylgalactosamine (UDP-
GalNAc) to UDP-glucose and UDP-N-acetylglucosamine (UDP-GlcNAc) (17-19). The human GalE 
not only contributes to the catabolism of dietary galactose, but also reversibly enables the endogenous 
biosynthesis of both UDP-galactose and UDP-N-acetylgalactosamine when exogenous sources are 
limited. Indeed, the enzymes of the Leloir pathway have attracted significant research attention for well 
over 30-40 years and the three-dimensional structures of all enzymes have now been defined (Table 1-
2 and Fig. 1-2). In detail, the first structure of GalM and GalK from Lactococcus lactis was determined 
by Thoden et al. (20-22). The structures of GalT and GalE from E. coli were also elucidated (23, 24). 
Recent advanced researches provide understanding of the function and structure of these enzymes in 
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Leloir pathway. 
Table 1-2 The three-dimensional structures of enzymes involved in the Leloir pathway 
from Protein Data Bank 
Enzymes EC Number Organisms PDB codea 
 
GalM 
 
EC 5.1.3.3 
Lactococcus lactis 
Homo sapiens 
Bacillus subtilis 
1MMU, 1MMX, 1MMY, 1MMZ, 1L7K 
1SNA, 1SNZ, 1SO0 
4BZE, 4BZF, 4BZG, 4BZH 
 
GalK 
 
EC 2.7.1.6 
Lactococcus lactis 
Homo sapiens 
Saccharomyces cerevisiae 
Pyrococcus furiosus 
1PIE 
1WUU 
2AJ4 
1S4E 
GalT EC 2.7.7.12 Escherichia coli 1HXQ 
 
 
 
GalE 
 
 
 
EC 5.1.3.2 
Escherichia coli 
Homo sapiens 
Archaeoglobus fulgidus 
Pseudomonas aeruginosa 
Brucella abortus 
Aspergillus nidulans 
Burkholderia pseudomallei 
1LRJ, 1LRK, 1LRL, 1A9Y, 1A9Z 
1EK5, 1EK6, 1HZJ 
3EHE 
1SB8, 1SB9 
4TWR 
4LIS 
3ENK 
aAll PDB codes are not shown in the table  
 
 
 
Fig. 1-2 The structures of enzymes involved in Leloir pathway.  
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1-2 Novel sugar metabolic pathways 
1-2-1 Intracellular degradation pathway in microbes that is linked to oxidative 
cellulose degradation 
 Although studies on cellulose degradating enzymes have been successfully achieved so far, it still 
remains question that how microbes metabolize cellobionic lactones produced by the combination of 
extracellular LPMOs and CBHs or CDH in the oxidative cellulose degradation pathway. Furthermore, 
how cellobionic lactones are connected to glycolysis has been unknown. In the old days, some results 
suggested that BGL hydrolyzes cellobionic acid (25, 26). However, cellobionic acid is an unsuitable 
and ineffective for BGL. It was also reported that the potential hydrolysate D-gluconic acid acted as a 
non-competitive inhibitor of BGL (27, 28).  
 After the function of LPMOs were clearly identified, a novel enzymecellobionic acid phosphorylase 
(CBAP) which can utilize cellobionic acid as the substrate was discovered by our collaborators (29). 
The intracellular CBAPs were characterized from the plant pathogenic bacterium Xanthomonas 
compestris and the cellulolytic fungus Neurospora crassa. The CBAPs were classified as new members 
of glycoside hydrolase family 94 (GH94 family). GH94 phosphorylases share (α/α)6 structural fold and 
catalyze reversible phosphorolysis of di- or oligosaccharides to produce sugar 1-phosphate and a sugar 
with particular substrate specificities in the intracellular catabolisms (Table 1-3). CBAPs (EC 2.4.1.321) 
catalyze reversible phosphorolysis of cellobionic acid (CbA) forming α-D-glucose 1-phosphate (αGlc1P) 
and α-D-gluconic acid (GlcA).  
In summary, cellulose is hydrolyzed into cellobiose by the combination of EG and CBH (Fig. 1-3). 
The resultant cellobiose is catalyzed into monosaccharides by BGL or also catalyzed into cellobiono-
1,5-lactone by CDH. Moreover, the LPMO oxidizes the C1 of crystalline cellulose and then the 
cellobiono-1,5-lactone is released by CBH from oxidized cello-oligosaccharide. The cellobiono-1,5-
lactone changes spontaneously to form cellobionic acid in water. The cellobionic acid is transported 
into the cytoplasm and phosphorolyzed into αGlc1P and GlcA by CBAP. The released αGlc1P is 
converted into D-glucose 6-phosphate by α-phosphoglucomutase (EC 2.7.5.1) for entering the 
glycolysis. Another released GlcA is converted into 6-phosphogluconate by the combination of 
gluconokinase (EC 2.7.1.12) and 6- phosphogluconate dehydrogenase (EC 1.1.1.44) for entering the 
pentose phosphate pathway. Therefore, CBAP is the new key enzyme that connects a “missing link” 
between the oxidative cellulose degradation and glycolysis and pentose phosphate pathway. The 
discovery of this pathway is contributed to understand the whole picture of the oxidative cellulose 
degradation pathway together with the discovery of the function of LPMOs.  
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Table 1-3 GH94 phosphorylase in CAZy database 
EC Name Cleaved bond Product 
2.4.1.20 Cellobiose phosphorylase D-Glc-β1,4-D-Glc α-D-Glc-1P 
2.4.1.31 Laminaribiose phosphorylase D-Glc- β1,3-D-Glc α-D-Glc-1P 
2.4.1.49 Cellodextrin phosphorylase D-Glc-( β1,4-D-Glc)n α-D-Glc-1P 
2.4.1.280 
N,N'–Diacetylchitobiose (chitobiose) 
phosphorylase 
D-GlcNAc- β1,4-D-GlcNAc α-D-GlcNac-1P 
 
 
 
Fig 1-3 Proposed overall cellulose degradation pathway. Enzymes are shown by blue 
characters. 
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1-2-2 Intracellular GNB/LNB pathway in Bifidobacterium longum 
Bifidobacteria are strictly anaerobic Gram-positive bacteria and usually found in the gastrointestinal 
tract (GIT) of humans and animals. It is well known that they significantly play a role in human health 
with the actions of various transporters, glycosidases, and metabolic enzymes (30). Bifidobacteria are 
the predominant intestinal bacteria in breastfed infants and grow in the human lower gastrointestinal 
tract where common mono- and disaccharides are insufficient (31). Additionally, bovine milk contains 
lactose, digested by lactase in the small intestine for infant, as the single saccharide, whereas human 
milk contains large amount of various oligosaccharides. HMOs (human milk oligosaccharides) are not 
able to be digested by enzymes in large intestine intact, where the HMO are potentially utilized by 
bifidobacteria. Therefore, Bifidobacteria is considered to have developed alternative pathways that 
utilize various oligosaccharides such as, the two type of human milk oligosaccharides, lactose, and 
mucin glycans (32-34) (Table 1-4). More than 130 types of HMOs have been isolated and they can be 
classified based on core structures type I and type II. Type I HMO, such as lacto-N-tetraose 
(Galβ1,3GlcNAcβ1,3Galβ1,4Glc), lacto-N-fucopentaose I (Fucα1,2Galβ1,3GlcNAcβ1,3Galβ1,4Glc), 
and lacto-N-difucohexaose I (Fucα1,2Galβ1,3[Fucα1,4]GlcNAcβ1,3Galβ1,4Glc) contain LNB (Gal-β 
1,3-GlcNAc), whereas type II HMO contain LacNAc (Gal-β 1,4-GlcNAc) (35, 36). Type I 
oligosaccharides are predominant in HMO but type II oligosaccharides are minor constituents. 
Interestingly, type I milk oligosaccharides are only found in human milk but not in other mammals’ 
milk (37).  
 
Table 1-4 Type of disaccharides metabolized by Bifidobacteria 
Name Structure Description 
Galacto-N-biose (GNB) Gal-β 1,3-GalNAc Mucin-type O-glycans 
Lacto-N-biose (LNB) Gal-β 1,3-GlcNAc Type I HMO 
N-Acetyllactosamine (LacNAc) Gal-β 1,4-GlcNAc Type II HMO 
Lactose Gal-β 1,4-Glc Major carbohydrate in mammal milk
 
 
 In 1999, Derensy-Dron et al. reported that lacto-N-biose phosphorylase (LNBP) from B. bifidum 
reversibly phosphorolyzes LNB to α-D-galactopyranose 1-phosphate (Gal1P) and N-acetyl-D-
glucosamine (GlcNAc) (38). The enzyme also phosphorolyzes galacto-N-biose (GNB, Gal-β 1,3-
GalNAc) to Gal1P and N-acetyl-D-galactosamine (GalNAc). In 2005, Kitaoka et al., found a novel 
putative operon from bifidobacterium longum JCM1217 containing the LNBP gene (lnpA). The lnpA 
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encodes LNBP enzyme which is a part of a putative operon. This operon was also identified in several 
species of bificobacteria, indicating that bifidobacteria possess a unique intracellular sugar metabolic 
pathway specific for LNB and GNB (39). Especially, it is well-known that LNB is a selective growth 
factor and a building block of the type 1 HMOs that is rich in human milk. Accordingly, a total of 208 
strains were investigated for the presence of the GLNBP gene and tested for growth in the presence of 
LNB as the sole carbohydrate source (40). Interestingly, all bifidobacterial strains do not grow and do 
not have the GLNBP gene. Only Bifidobacterium longum subsp. longum, B. longum subsp. infantis, B. 
breve, and B. bifidum strains were shown to have potentially the GLNBP gene (Table 1-5). The GLNBP 
gene (BL1641) is located in a putative operon in the B. longum NCC2905. In the operon, BL1642, 
BL1643, and BL1644 are annotated as N-acetylhexosamine 1-kinase (NahK, EC 2.7.1.162), galactose-
1-phosphate uridylyltransferase (GalT, EC 2.7.7.10), and UDP-galactose 4-epimerase (GalE, EC 
5.1.3.2), respectively (Fig. 1-4A) (32).  
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Table 1-5 The growth patterns in bifidobacterium (40). (Xiao, J. et al., Appl Environ Microbiol 
76, 54-59, 2010) 
Species Strains Origin 
Growth patterna 
LNB Lactulose Glucose
B. longum subsp. longum IV-51 (same as 
ATTCC 15707T) 
Feces of adult 5 4 5 
ATCC 15708 Feces of infant 2 2 4 
MCC strains Feces of adult or infant 2-5 5 5 
B. longum subsp. infantis IV-8 (same as ATCC 
15697T) 
Infant 5 5 5 
MCC strains Adult, infant 2-5 1-5 2-5 
B. breve IV-14 (same as ATCC 
15700T) 
Infant 5 5 5 
MCC strains Infant or from yogurt 2-5 3-5 1-5 
B. bifidum ATCC 15696 Intestine of infant 5 5 4 
MCC strains Feces of infant 5 5 3-5 
B. adolescentis ATCC 15706 Feces of adult 0 1 2 
ATCC 15705 Feces of adult 0 2 2 
MCC strains Feces of adult or Infant 0 0-3 0-4 
B. catenulatum ATCC 27675 Feces of human 0 2 2 
MCC strains Feces of adult 0 1-5 2-5 
B. longum subsp. animalis IV-58 (same as ATCC 
25527T) 
Feces of rat 0 4 4 
B. longum subsp. lactis DSM 10140 Yogurt 0 4 5 
MCC strains Yogurt 0 4-5 5 
B. Thermophilum MCC strinas Feces of animals 0 0-5 4-5 
 
aThe growth pattern was categorized from 0 to 5 based on OD600 measured at 24h (OD24 h) and 144h (OD144 h).0, 
no growth (OD144 h <0.1); 1, slow and mild growth (OD24 h <0.1; OD144 h =0.1 to 0.5); 2, slow but strong growth 
(OD24 h <0.1; OD144 h >0.5); 3, intermediate and mild growth (OD24 h =0.1 to 0.5; OD144 h =0.1 to 0.5); 4, 
intermediate and strong growth (OD24 h =0.1 to 0.5; OD144 h > 0.5); 5, quick and strong growth(OD24 h >0.5) 
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 The downstream genes (LnpB-LnpD) were cloned and characterized for the properties of enzymes in 
B. longum JCM1217 (32). NahK encoded by LnpB can phosphorylate the anomeric1-position of both 
GlcNAc and GalNAc. GalT encoded by LnpC and GalE encoded by LnpD are involved not only in the 
general glucose/galactose metabolism, but also in GlcNAc/GalNAc metabolism. In the view of enzyme 
specificity, GalT and GalE can utilize both hexose 1-phosphate and N-acetylhexosamine 1-phosphate, 
and both UDP-Gal and UDP-GalNAC as substrates, respectively. The metabolic pathway encoded by 
this operon was called as GNB/LNB pathway. These enzymes involved in GNB/LNB pathway can send 
GNB and LNB molecules to glycolysis and aminosugar metabolism (Fig. 1-4B)  
The GNB/LNB pathway can be considered to an energy-saving pathway compared to Leloir pathway. 
In the Leloir pathway, galactose is phosphorylated by galactokinase, comsuming ATP. However, 
GLNBP produces galactose 1-phosphate without consuming ATP. The GNB/LNB pathway is the main 
novel sugar metabolic pathway for HMO and mucin O-glycans as an energy source in B. longum.  
 
Fig 1-4 Scheme of the GNB/LNB pathway in Bifidobacterium longum (A) The schematic 
structure of the gene cluster encoding the pathway in b. longum JCM1217, (B) Schematic representation 
of the GNB/LNB pathway. 
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1-3  The aim of this thesis 
 Glycolysis, the major pathways of carbohydrate metabolism, have evolved to process the hexose 
monosaccharide glucose. Many of the enzymes in the glycolytic pathway are so specific for 
monosaccharide glucose that even other sugars are not processed at any appreciable rate. To get over 
this problem, microorganisms would use number of unknown short pathways for converting other 
common sugars. When some novel enzymes would be discovered and characterized though biochemical 
analysis, the short pathways could be revealed and provided to information for understanding biological 
mechanisms. 
 In this general introduction, I described two novel sugar metabolic pathway finally connected to the 
glycolytic pathway. However, some enzymes related to each pathway have been still required for 
understanding biochemical process and the detailed molecular mechanism.  
1) In the oxidative cellulose degradation pathway, hydrolytic enzymes (cellulases) have been well 
studied in aspect of functional and structural features. Even though cellobionolactone yielded by the 
combination of LPMOs and CBHs was recently revealed to be catalyzed by intracellular cellobionic 
acid phosphorylase, there was no information about substrate recognition residues and catalytic 
mechanism based on crystal structures. In chapter 2, therefore, X-ray crystallography was conducted 
on CBAP from the marine bacterium Saccharophagus degradans 2-40 for identifying the catalytic 
residues and understanding the phosphorolysis reaction mechanism. This study would provide basic 
information for the further investigation of cellulose degradation pathway and the future design of 
phosphorylases with altered substrate specificity. 
2) The GNB/LNB pathway is a unique pathway for the metabolism of GNB and LNB as the sole 
carbohydrate source, only found in some bifidobacteria as described in Fig 1-4. The four intracellular 
enzymes sequentially convert GNB and LNB and send the products to downstream pathways. The 
crystal structures of intracellular enzymes belonged to GNB/LNB pathway have been only reported in 
GLNB phosphorylase (41) and NahK (42). The crystal structures of GalT and GalE related to 
GNB/LNB pathway are not reported yet. Both of these enzymes have broad substrate specificity 
compared to general GalT and GalE enzymes belonged to Leloir pathway because they can catalyze 
UDP-GlcNAc/GalNAc in in addition to UDP-Glc/Gal. It needs to be discussed about the reasons why 
the both enzymes have different substrate specificity from homologous enzymes in Leloir pathway. 
Research of these two sugar metabolic enzymes provide beneficial tools in the investigations of 
relationship between structure and function of oligosaccharide biocatalytic enzymes and for wide range 
of applications in biomass utilization, nutrition, and medicine development. 
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Chapter 3 X-ray crystallography of UDP- glucose hexose 1-
uridylytransferase and UDP-galactose 4-epimerase in GNB/LNB pathway 
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3-1 Introduction 
 The intracellular GNB/LNB pathway is a novel sugar metabolic pathway in B. longum for human milk 
oligosaccharides and intestinal mucin glycoproteins. UDP-glucose hexose 1-phosphate 
uridylyltransferase (GalT) and UDP-galactose 4-epimerase have been conserved (GalE) from 
Escherichia coli to humans. The enzymes involved in the GNB/LNB pathway sequentially convert 
GNB/LNB into αG1P and GlcNAc 1-phosphate. These enzymes were characterized and distinguished 
in the aspect to substrate specificity with homologue enzymes involved in Leloir pathway (1). 
Interestingly, UDP-glucose hexose 1-phosphate uridylyltransferase (bGalT) and UDP-galactose 4-
epimerase (bGalE) from B. logum are involved not only in typical glucose/galactose metabolism, but 
also in the GlcNAc/GalNAc metabolism. It was reported that impairment of these enzymes in the Leloir 
pathway in yeast causes the disease galactosemia and metabolic disorder (2). They also regulates the 
intracellular homeostasis of the UDP-glucose/UDP-GlcNAc and UDP-galactose/UDP-GalNAc for 
aminosugar metabolism. As described in the general introduction, the crystal structures of GNB/LNB 
phosphorylase and N-acetylhexosamine 1-kinase (NahK) have been reported (3, 4). On the other hand, 
the structural studies of bGalT and bGalE have not been accomplished yet. Therefore, I conducted 
crystallization screening of bGalE and bGalT. A preliminary structure of bGalT was solved at 2.4 Å 
resolution by a molecular replacement method, but crystallographic refinement is not sufficiently done 
yet. In this chapter, I mainly describe about X-ray crystallography of bGalE focusing on its wide 
substrate specificity. 
GalE from E. coli (eGalE), which has been extensively studied, catalyzes only the conversion between 
UDP-Gal and UDP-Glc (5-7). On the other hand, human GalE (hGalE) shows a broad substrate 
specificity similar to bGalE, catalyzing the conversion of both UDP-Gal/UDP-Glc and UDP-
GalNAc/UDP-GlcNAc (8, 9). Moreover WbpP from Pseudomonas aeruginosa preferentially catalyzes 
the conversion between UDP-GalNAc and UDP-GlcNAc (10). The GalE enzymes can be classified into 
three main groups based on their substrate specificity but they do not make clear clusters in the 
phylogenetic tree (Fig. 3-1) (10, 11). Group 1 represents epimerases which catalyze the conversion 
between UDP-glucose and UDP-galactose, such as the eGalE, and Trypanosoma brucei GalE (tGalE). 
The difference between group 1a and group 1b is only the size of the sugar binding pocket (discussed 
after). tGalE has too small saccharide binding pocket to bind acetylated UDP-hexose (group 1a). Group 
2 represents epimerases which can catalyze both UDP-Glc/UDP-GlcNAc into UDP-Gal/UDP-GalNAc, 
such as hGalE and bGalE. Group 3 represents epimerase which can strongly catalyze acetylated 
substrate, such as WbpP.  
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Fig. 3-1 Phylogenetic tree based on substrate specificity for UDP-hexose 4-epimeraes. 
A phylogenetic tree was prepared using 30 sequences, which were aligned using ClustalW2 
(12) and the tree was drawn using the FigTree program. Asterisks indicate structure-known 
members. 
 
 Even though many numbers of epimerases classified in group 2 have been characterized for 
biochemical properties (13-15), the structural approaches are accomplished in only hGalE. In this 
chapter, the structural characterization of bGalE in complex with UDP-GlcNAc and UDP-Glc could 
support the biochemical information to understand the structural basis of substrate specificity, 
comparing with the structural properties of group 1, 2, or 3 epimerases (8-10, 16). 
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3-2 Materials and Methods  
 
3-2-1 Protein expression check 
 LnpC (bGalT) and lnpD (bGalE) plasmids were transformed into E. coli BL21-CodonPlus (DE3) and 
incubated in 3 ml of Luria-Bertani (LB) medium containing 50 ug/ml kanamycin and chloramphenicol, 
until the absorbance reached OD 0.6 at 600 nm. The proteins were expressed by range from 0 to 1 mM 
of isopropyl β-D-thiogalactopyranoside (IPTG) and incubated on different temperatures: 37 ºC for 3 
hours, 30 ºC for 8 hours, and 25 ºC for 20 hours. The expressed proteins were confirmed by SDS-PAGE. 
 
Fig 3-2 Protein expression check for bGalT and bGalE 
 
3-2-2 Protein Preparation 
 The nonlabeled bGalT was expressed at 25 ºC for 20 hours after adding 0.1 mM IPTG in 1 L of LB 
medium. The cells were collected and suspended in 50 mM Tris-HCl buffer, pH 8.0 and then disrupted 
by sonication (Cosmo Bio). The cell debris was removed by ultracentrifugation at 10,000 × g for 30 
min. The cell-free extract was subjected to Ni-affinity chromatography column (HisTrap™ FF crude 
5ml, GE Healthcare). The enzyme was eluted with a two steps of 20 mM and 250 mM imidazole in 50 
mM Tris-HCL buffer, pH 8.0. The enzyme was then further purified on a column of Mono Q colum (GE 
Healthcare) with an increasing linear gradient of 0-100% saturation of sodium chloride by using an 
ÄKTA (GE Healthcare). The molecular mass of purified bGalT was estimated by SDS-PAGE and by 
gel filtration chromatography (HiLoad 16/60 Superdex 200 pg; GE Healthcare) equilibrated with 50 
mM Tris-HCl buffer, pH 8.0 containing 150 mM NaCl at a flow rate of 1.0 ml/min. The 
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selenomethionine-labeled protein was expressed in methionine auxotroph E. coli strain B834 (DE3) 
(Novagen) in medium containing selenomethionine. The procedures of purification were performed as 
the same as those for non-labeled bGalT protein. 
 The bGalE was expressed at 25 ºC for 20 hours after adding 0.1 mM IPTG in 1 L of LB medium. The 
cells were collected and supended in 50 mM Tris-HCl buffer, pH 7.0 and 0.1 mM PMSF. The supernatant 
was sequentially purified on Ni-affinity chromatography with a two steps of 20 mM and 250 mM 
imidazole in 50 mM Tris-HCL buffer, pH 7.0 and gel filtration chromatography equilibrated with 50 
mM Tris-HCL buffer, pH 7.0 containing 150 mM NaCl at a flow rate of 1.0 ml/min.
 
Fig. 3-3. Gel-filtration chromatography. Both of bGalT and bGalE proteins exist as dimer in 
solution. 
 
3-2-3 Crystallization 
 The proper concentrations of bGalT and bGalE for crystallization screenings were determined by Pre-
Crystallization Test (Hampton Research). The initial screenings for crystallization of bGalT and bGalE 
was performed using Nextal JCSG+ suit, JCSG Core I-IV suit, Crystal screen I&II, and Wizard I&II. 
Crystals were prepared by sitting drop vapor diffusion method using mixing 1:1 volume of enzyme and 
reservoir solutions at 4ºC. 
 The bGalT were crystallized with 0.1 M ammonium acetate, 0.1M Bis-Tris buffer, pH 5.5, 17% (w/v) 
PEG 10,000, 10 mg/ml protein and 10 mM UDP. After crystal condition was optimized to 0.14-0.18 M 
Bis-Tris buffer, pH 5.5, 17% (w/v) PEG 1,000, 10 mg/ml protein and 10 mM UDP. The optimized crystal 
condition was tested as the same method for selenomethionine-labeled bGalT. 20% (v/v) glycerol was 
used as cryoprotectant before data collection. 
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For successful crystallization of bGalE, the reservoir solution consisted of 0.1 M HEPES buffer, pH 7.5, 
0.2M magnesium chloride, and 30% (v/v) PEG 400, whereas the drop consisted of 7 mg/ml bGalE, 
either 10 mM UDP-GlcNAc or 10 mM UDP-galactose. The crystals were not obtained without co-
crystallization with UDP-substrates. 
 
3-2-4 Data collection 
The diffraction data set of native bGalT were collected at a wavelength of 0.97319 Å on beam line 
BL17A of the Photon Factory, KEK. The single wavelength anomalous dispersion (SAD) data sets for 
the selenomethionine-labeled crystal, 20 mM HgCl2 soaked crystal, and 20 mM K2Pt(NO2)4 soaked  
crystal were collected at wavelength of 0.97876 Å, 1.00847 Å, and 1.0000 Å on beam line of NE3A, 
BL17A. All data sets were carried out and scaled using HKL2000 (17). 
X-ray diffraction data sets of bGalE were collected using synchrotron radiation at beam lines BL17A, 
BL5A, and NW12A of the photon Factory, and data were processed and scaled using the HKL2000 
program.  
 
3-2-5 Phase calculation of bGalT 
The anomalous signal of selenium atom from 8 methionine residues was evaluated. The initial phase 
calculation and phase improvement was performed by experimental phasing with program the PHENIX 
AutoSol and AutoBuild (18). The quality of the phases was insufficient (figure of merit = 0.175 for all 
reflections) to obtain an ambiguous map at 3.25 Å resolution  
 
3-2-6 Molecular replacement and Refinement of bGalE 
 The native structure was solved by molecular replacement (Molrep software) using human GalE 
(hGalE; PDB code 1EK6) as a template (19). Automated model building and refinement was performed 
using the MR and Refmac5 suite in CCP4, respectively. Manual model rebuilding and refinement were 
performed using Coot (20). All figures were prepared using PyMol [http://www.pymol.org] and ESPript 
(21). 
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3-3 Results 
 
3-3-1 Crystallization and data collection of bGalT and bGalE 
 Crystals of bGalT were obtained in 0.1 M ammonium acetate, 0.1 M Bis-Tris pH 5.5, 17% (w/v) PEG 
10,000 and 10 mg/ml of protein at 4 ºC (Fig. 3-4A). After optimized crystallization condition with 
0.14~0.18 M ammonium acetate, 0.1 M Bis-Tris pH 5.5, 17% (w/v) PEG 1,000 and 10 mg/ml of protein, 
the crystals of bGalT were bigger in size (Fig. 3-4B). The crystallization of selenomethionie-labeled 
(SeMet) bGalT was performed on the same condition of optimized for the native crystals. However, the 
crystals of SeMet bGalT were smaller than native crystals in size and the resolution was poor for 
determination of phase (Fig. 3-4C). The biggest problem was that the native and SeMet crystals were 
twinned. In case of native crystals, the advanced beam line and the big size of crystals helped to get an 
enough resolution in spite of forming twin crystals. On the other hand, the SeMet were too small to 
collect a data set with enough resolution for complete structure determination. Therefore, heavy atoms 
were soaked into big native crystals. Even though the resolution was improved, cell constants were 
different with the native crystals. Crystallographic refinement is currently in progress with SeMet data 
sets. The all data collections of bGalT are described in Table 3-1. 
  
Fig. 3-4 Crystals of bGalT and bGalE. (A) First obtained bGalT crystals. (B) Optimized bGalT 
crystals. (C) Selenomethionie-labeled bGalT crystlas. (D) bGalE crystals. 
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Table 3-1 Data collection of bGalT 
 
α Values in parentheses correspond to the highest resolution shell 
 
The crystals of bGalE were pillar-shaped (Fig. 3-4D). The first data collection of bGalE was obtain to 
2.4 Å resolution. The crystal got radiation damage easily because of the shape of bGalE. The beamline 
in Photon Factory supported the helical mode, which could help to collect data with low radiation 
damage on crystals (Fig. 3-5).  
 
Fig. 3-5 Data collection used by helical mode. 
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3-3-2 Overall structure of bGalE 
All crystals of bGalE belong to the P6522 space group. The structures of bGalE in complex with UDP, 
UDP-GlcNAc, and UDP-Glc were determined at 1.8, 2.0, and 1.8 Å resolution to R factor (R free) of 
16.4% (18.9%), 19.3% (23.0%), and 16.9% (19.6%), respectively (Table 3-2). The UDP-glucose 
complex was obtained by co-crystallization with 10 mM UDP-Gal, indicating that bGalE catalyzes the 
interconversion of the 4'-hydroxyl configuration. One molecule contained in an asymmetric unit of the 
crystal, whereas bGalE exists as a homodimer in solution (Fig. 3-3). The bGalE forms a homodimer by 
the formation of a four-helix bundle with each two α-helices. The overall protein structure can be 
roughly divided into an NAD+ binding N-terminal domain (residues 1-177 and 236-262) and an UDP-
hexose binding C-terminal domain (residues 178-235 and 263-340) (Fig. 3-6). The structure of bGalE 
adopts a typical Rossmann fold composed of a seven-stranded parallel β-sheet flanked by nine α-helices. 
The cofactor NAD+ was intrinsically bound to all complexes. It was reported that all crystal structures 
of GalE contained NAD+ or NADH molecule (8, 22). The UDP-hexose binding C-terminal domain 
possesses an α/β motif consisting of four α-helices and four β-strands. According to superimpositions 
of α-carbons with homologous GalEs, root mean square deviation (RMSD) showed 0.870 Å, 0.819 Å, 
1.372 Å, and 0.759 Å in hGalE (PDB 1E6K), eGalE (PDB 1XEL), WbpP (PDB 1SB8), and GalE from 
Trypanosoma brucel (tGalE; PDB 2CNB), respectively (23). The bGalE structure is basically similar 
to those of homologous GalEs (Fig. 3-7), except for WbpP from Pseudomonas aeruginosa, which has 
an additional α-helix in the N-terminal domain (residues 3-16) (10).  
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Fig. 3-6 Overall structure of bGalE. (A) Homodimer (B) Monomer; The magenta and orange 
sticks indicate UDP-GlcNAc and NAD+, respectively. 
 
 
Fig. 3-7 Superimposition with homologous GalEs and NAD binding loops. bGalE (green), 
hGalE (cyan), eGalE (magenta), tGalE (yellow), and WbpP (orange) are shown. Inset, NAD+ 
binding loop (residues 31-37 in bGalE). 
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Table 3-2 Data collection and refinement statistics. 
 
aValues in parentheses correspond to the highest resolution shell. 
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3-3-3 NAD+ binding site 
The electron density of the NAD+ coenzyme bound in active site was clearly observed, which helped 
us to place the ligand with reasonable accuracy (Fig. 3-8). Moreover, the position of the nicotinamide 
ring of the dinucleotide was bound in the syn conformation. The nicotinamide ring of NAD+ in all 
complexes of GalEs in the oxidized form adopts the syn conformation (7, 24). The N6 atom f the adenine 
base interacts with the side chain of Asp59 and Asn100. The N7 atom forms a hydrogen bond with the 
side chain of Asn100, which corresponds to Val107 in hGalE and Asn 99 in eGalE. The hydroxyl groups 
of the adenine ribose interact with the NAD+ binding loop formed by Asp32, Asn33, Gly35, Asn36, and 
Ser37. The NAD binding loop exists in all homologue GalE (Fig. 3-7). The adenine phosphate interacts 
with the side chain Asn36, the backbone amide hydrogen of Phe12, and water molecule. On the other 
hand, the nicotinamide phosphate interacts with the backbone amide hydrogen of Ile13, the side chain 
of Lys85, and water molecule. The hydroxyl groups of the nicotinamide ribose interact with the side 
chain of Tyr150, Lys154, with the main chain of Phe81, and two water molecules. The nicotinamide 
ring interacts with only two water molecules.  
 
Fig. 3-8 NAD binding site (stereoview). Blue and yellow sticks indicate UDP-GlcNAc and 
NAD+, respectively. Magenta residues represents NAD binding loop. Hydrogen bonds are 
shown in yellow dash lines. The 2Fo-Fc electron density map is shown as blue mesh and 
contoured at 1.5 σ. Red spheres indicate water molecules.  
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3-3-4 UDP-hexose binding site 
Crystal structures of bGalE were determined also in complex with UDP-GlcNAc and UDP-glucose. 
Hydrogen bonding interactions between the enzyme and UDP-hexose ligand are indicated by the dashed 
lines in Fig. 3-9. There are 10 electrostatic interactions within 3.5 Å between the enzyme and the UDP 
hexose ligand. The uracil ring is recognized by the backbone carbonyl and amide groups of Gln217 and 
Tyr219. The 2'-hydroxyl group of the ribose interacts with the carboxylate side chain of Asp295 and 
this interaction was conserved on all homologous GalE (Fig. 3-10). Phosphate groups are recognized 
by backbone carbonyl Leu201 and the side chain of Arg232 and Arg292. In Fig 3-9 A, N-acetyl group 
of UDP-GlcNAc interacts with the side chain of Lys85 and one water molecule. The 2', 3', and 4'-
hydroxyl groups of GlcNAc interact with the backbone carbonyl of Lys85, the side chain of Tyr150, 
and the side chain of Ser125. These interactions were are present in UDP-glucose complex (Fig. 3-9 B). 
On the other hand, there is a unique interaction in only UDP-glucose complex compared to UDP-
GlcNAc complex. In structural superimposition between UDP-GlcNAc and UDP-glucose complex, the 
side chain conformation of Asn200 at the UDP-hexose binding site is different; it swings “in” or “out” 
in the UDP-glucose and UDP-GlcNAc complex structures, respectively (Fig. 3-9 C). This phenomenon 
was also reported for the orientation of Asn207 in UDP-GlcNAc complex as shown in one of subunits 
in the hGalE (8).  
 In both complex structures, the C4 atom of the UDP-GlcNAc/UDP-Glc was positioned at  distances 
of 3.2 Å and 3.4 Å from the C4 atom of the nicotinamide ring of the dinucleotide, respectively. In the 
proposed reaction mechanism of GalE, a hydride transfer is thought to occur between thse atoms (7). 
Additionally, the catalytic base Tyr150 which is conserved in all GalE enzymes, was positioned at 2.6 
Å from the C4 atom of the UDP-GlcNAc/Glc. Therefore, these observation in UDP-hexose binding site 
was clearly elucidated that GlcNAc and glucose moieties in the complex structure are in the catalytically 
competent substrate orientation. 
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Fig. 3-9 UDP-hexose binding site of bGalE (Stereoview). (A) UDP-GlcNAc complex. (B) 
UDP-Glc complex. (C) Superimposition of UDP-GlcNAc and UDP-Glc complex. Hydrogen 
bonding interactions between the enzyme and the UDP-hexose ligand are indicated by dashed 
lines. Red dash lines indicate the distance between the C4 atom of the UDP-hexose and the 
C4 atomof the nicotinamide ring. 
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Fig. 3-10 Partial amino acid sequence alignment of GalE enzymes. Structure based 
aminoacid sequence alignment of the bGalE from B. longum, hGalE from human, eGalE from 
E. Coli, tGalE from Trypanosoma brucei, aGalE from Archaeoglobus fulgidus, pGalE from 
Pyrobaculum. Calidifontis, and WbpP from Pseudomonas aeruginosa.The residues in square 
box indicate one of the six side walls composed of substate binding pocket. Blue stars indicate 
the SYK catalytic triad. 
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3-3-5 Structural basis for substrate specificity in bGalE 
According to the superimposition of substrate binding pocket in represented group 1, 2, and 3 enzymes 
(Fig. 3-1), all GalE enzymes conserved the residues Ser, Tyr, and Asn (Fig. 3-11; S125, Y150, and N180 
in bGalE). They are part of the conserved SYK catalytic triad (tGalE: S142, Y173, and K177; eGalE: 
S124, Y149, and K153; hGalE: S132, Y157, and K161; bGalE: S125, Y150, and K154; WbpP: S142, 
Y166, and K170 shown in Fig. 3-10). In the superimposition of bGalE and hGale in complex with UDP-
GlcNAc, the residues were conserved well and N200/N207 adapts the “swing out” conformation to 
accommodate N-acetylated sugar (Fig. 3-11A). The asparagine in bGalE moves to the “swing in” 
conformation, when UDP-Glc sugar is bound to active site, as described in Fig. 3-9C. In the case of 
eGalE, the Asn199 was fixed in the “swing in” conformation, whatever substrates were bound to active 
site (25). The bulky side chain of Tyr299 in eGalE makes the saccharide binding pocket narrower, in 
comparison with Cys299 in bGalE. It was discussed that the bulky Try299 of eGalE interrupts the 
binding of flipped UDP-4-keto-GlcNAc as intermediate (25). In eGalE in complex with UDP-GlcNAc 
(PDB 1LRJ), it was reported that acetylated moiety of sugar was bound in a wrong position and the 
interaction between 2'-hydroxyl group of UDP-GlcNAc and Asn199 was missing, because of the bulky 
Tyr299 (25). However, Y299C mutant resulted in an overall 20% increase in the volume of the 
saccharide binding pocket and a loss of epimerase activity to UDP-Gal but an increase of activity to 
UDP-GalNAc (Table 3-3) (25). In comparison between bGalE and WbpP in active site, Ala209 had the 
same orientation with Asn200 in bGalE structure, even though UDP-GalNAc is in a “flipped” 
conformation. The Ala209 residue does not show any “swing in or out” in the substrate binding pocket. 
The small Ala209 and Sre306 residues make a bigger saccharide binding pocket comparing with other 
homologous GalE enzymes that have Tyr here. According to these results, the small size residues (Cys 
or Ser) allowed accommodating the large N-acetylated sugar into the saccharide binding pocket of GalE 
enzymes.  
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Fig. 3-11 Substrate binding pockets in GalE enzymes. (A) Superimposition of bGalE (green) 
and hGalE (blue). (B) Superimposition of bGalE (green) and eGalE (orange). (C) 
Superimposition of bGalE (green) and WbpP (flipped; yellow). 
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3-4 Discussion 
The cofactor NAD+ was intrinsically bound to bGalE without an addition in solutions throughout my 
experimental processes in all complexes, indicating that NAD+ is tightly bound to GalE. It was reported 
that when NAD was removed out from GalE, the protein was irreversibly denatured (7, 9). In contrast 
to GalE enzymes, NAD-dependent dehydrogenases, L-ThrDHs from the psychrophilic bacterium 
Flavobacterium frigidimaris KUC-1, can easily release NAD+ from the enzymes (26). According to the 
structural comparison of L-ThrDHs with eGalE and hGalE, overall structure was similar but topology 
was different in the loop around the NAD binding site and the NAD binding loop was absent in L-
ThrDHs (26). Moreover, Sakuraba et all. constructed GalE loop deletion mutant for investigating the 
role of the NAD binding loop (26). The mutant formed inclusion body during the purification and lost 
epimerase activity. The all GalE homologues have the NAD binding loop and the interactions between 
NAD and residues around the NAD binding loop are conserved. Therefore, the NAD binding loop plays 
a key role in preventing the release of the cofactor from GalE enzymes and contributing to the stability 
of protein. 
In enzyme activity of GalE enzymes (Table 3-3), it was reported that bGalE catalyzes both acetylated 
and non-acetylated substrates with comparable activities. The hGalE can also equally epimerize both 
UDP-GalNAc and UDP-gal. On the other hand, eGalE is highly specific for UDP-gal, whereas WbpP 
shows strong preference for acetylated substrates  
 
Table 3-3. Enzyme activities of GalE enzymes. 
 UDP-Glc UDP-Gal UDP-GlcNAc 
UDP-
GalNAc Note Ref.
bGalE – 158 147 – Specific acitivity (U/mg) at 1 mM UDP-sugar (1) 
hGalE – 33.8 – 26 
Specific acitivity (U/mg) at 0.41 mM 
UDP-Gal or 0.66 mM UDP-GalNAc (25)eGalE – 23.9 – 0.003 
eGalE 
(Y299C) – 5.1 – 0.69 
tGalE – 5.9 – – Specific activity (U/mg) at 20 mM UDP-Gal (27)
WbpP 0.124 0.188 120 271 kcat (min
-1). Km values were similar for 
all substrates (197~251 uM) (28)
 
 These GalE enzymes have been well characterized, and their catalytic mechanisms were studied well 
with their structural properties (Table 3-4) (1, 25, 27, 28). However, Ishiyama and Demendi et al. 
mentioned (10, 11) that the most studies of GalE enzymes have focused on refining the catalytic 
mechanism (5-7, 9, 29-32). Only few have studied the molecular basis for substrate specificity (8, 13, 
15, 25, 33). Thus, they constructed a conceptual model to facilitate a better understanding of the factors 
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governing the substrate specificity spectra in GalEs based on the analysis of the relationship between 
amino acid sequence, three-dimensional structure, and substrate preference (Fig. 3-12) (10, 11).  
 
 
Fig. 3-12 A conceptual model for saccharide-binding pockets and substrate specificity 
spectra in GalEs. The substrate specificity spectra of tGalE, eGalE, hGalE, bGalE, and WbpP 
are represented by modifying Fig. 5 in reference (10). The sugar moieties of UDP-Glc(NAc) 
bound in the catalytically productive conformation (“standard” orientation) are represented as 
black solid lines. Similarly, the sugar moieties of UDP-Gal(NAc) bound in the “flipped” 
orientation are represented as dashed lines. 
 
In the conceptual model, tGalE, eGalE, hGalE, bGalE and WbpP are classified into Group 1a, 1b, 2, 
2, and 3 based on their substrate specificity, respectively. The bottom of the hexagonally shaped box is 
formed by the nicotinamide ring of the NAD cofactor and six walls are formed by different regions of 
the enzymes. The sugar moieties of UDP-Glc(NAc) or UDP-Gal(NAc) bound in the saccharide binding 
pocket in the “standard” orientation that was observed in bGalE, hGalE, and eGalE (Fig. 3-11AB). On 
the other hand, the “flipped” orientation that was observed in WbpP (Fig. 3-11C, yellow) is shown as 
dashed lines. A magenta wall in eGalE, hGalE, and bGalE are open by the “swing out” rotation of Asn 
side chain to accommodate the rotation of the saccharide ring for the reaction mechanism. The 
saccharide binding pocket in tGalE is fully closed by six walls, allowing to bind only non-acetylated 
UDP-hexose whereas the saccharide binding pocket in eGalE is semi-open by Asn199, indicating that 
acetylated hexose could bind and the 4-keto intermediate could be formed. However, flip of sugar 
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moiety is blocked by the bulky residue Y299 for epimerase reaction. It was reported that when the 
structural equivalent of Tyr299 in E. coli GalE was substituted with Cys, resulting in a loss of epimerase 
activity to UDP-Gal by almost 5-fold and resulting in a gain of activity against UDP-GalNAc by more 
than 230-fold (Table 3-3) (25). Thus, this mutation of eGalE changed its substrate spectrum from group 
1 to group 2. Actually, the saccharide binding pocket of bGalE is basically the same as that of hGalE. 
In group 2 and 3 enzymes, two walls adopt a semi-open or open form to accommodate the acetylated 
substrate. Especially, the small side chains of cysteine and serine make enough space to bind N-
acetylated sugar compared to leucine and tyrosine in group 1.It also allow to occur the flipped rotation 
of the N-acetylated sugar in the saccharide binding pocket. Moreover, in group 3 WbpP, two of the walls 
are removed by shorter side chain alanine and serine, contributing to make additional space for binding 
ordered water molecules in active site, which can be enabled to bind N- acetylated sugar. Water 
molecules in this site (shown as spheres in Fig. 3-12) are thought to contribute to the strong preference 
to UDP-GlcNAc/GalNAc than UDP-Glc/Gal (10). 
 
 For easily understanding the substrate binding pocket size, the active sites in GalE enzymes are 
visualized by a molecular surface model (Fig. 3-13). In the substrate binding pockets of both bGalE and 
hGalE, magenta and green walls make an enough space to bind the N-acetyl group in both of the 
“standard” and “flipped” orientations. On the other hand, in eGalE, the green wall is obviously 
protruded toward the active site, causing interruption of sugar moiety rotation. WbpP has a biggest 
substrate binding pocket in GalE enzymes. The magenta and green wall are far away from active site 
and allow to accommodate acetylated sugars. In conclusion, these different shapes and sizes of the 
saccharide binding pocket in GalE enzymes lead to the distinctive substrate specificity. 
 39 
 
 
Fig. 3-13 Visualized substrate binding pockets in GalE enzymes. (A) bGalE in complex 
with UDP-GlcNAc. (B) hGalE in complex with UDP-Glc. (C) eGalE in complex with UDP-Glc. 
(D) WbpP in complex with UDP-GalNAc (flipped). The residues of colored surface are 
described in Fig. 3-13. 
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In the proposed epimerase reaction mechanism of GalE (Fig. 3-14), the first step is an abstraction of a 
hydride from the C4 hydroxyl group of UDP-Glc(NAc), leading to hydride transfer to the C4 atom on 
the si-face NAD+, and formation of UDP-4-keto-Glc(NAc) and NADH as an intermediate state (Fig. 3-
14). Next, UDP-4-keto-Glc(NAc) in the active site rotates and is positioned the opposite face of the 
sugar to the reduced dinucleotide. Finally, the nicotinamide ring of NADH transfers the hydride back 
to the opposite face of C4 keto-intermediate and the intermediate sugar forms the epimer.  
 
 
Fig. 3-14 Mechanism of UDP-galactose 4-epimerase. 
 
 In general introduction, I described that all bifidobacteria do not have the GLNBP and do not utilize 
GNB/LNB pathway. LNB and GNB are present in human milk and human gastrointestinal tract. 
Especially, type I oligosaccharides are predominant in HMO. bGalE involved in GNB/LNB pathway 
could be specialized for GNB and LNB saccharide during molecular evolution. Moreover, the substrate 
specificity of GalEs can not be easily predicted by amino acid sequence by a phylogenetic tree analysis 
(Fig. 3-1). But a few amino acids (ex N200 and C299 in bGalE) are responsible for that. Therefore, 
many studies about GalE enzymes have showed that substrate specificity can be modified by simply 
changing one or two residues at active site (5, 25, 31, 34). Thus, Demendi et al. proposed substrate 
specificity modification of WbpP enzyme by the binding pocket residues have co-evolved with early 
evolution of group 1a, 1b, 2, and 3 (11).  
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A survey for GalE structures complexed with UDP-hexose substrates in catalytically competent 
conformations is shown in Table 3-4. The “flipped” orientation was not easily observed with natural 
substrates and wild-type enzymes, except for WbpP complexed with GlcNAc. In eGalE, a flipped 
orientation structure was only observed by using a S124A/Y149F double mutant (5). For tGalE, a 
flipped structure was determined by using a substrate analog UDP-4-deoxy-4-fluoro-α-galactose (UDP-
4fGal) (34).  
 In conclusion, the crystal structure of bGalE involved in the GNB/LNB pathway showed a structural 
basis of a UDP-galactose 4-epimerase that catalyzes the conversion between UDP-GlcNAc and UDP-
GalNAc or UDP-Glc and UDP-Gal. According to the structural basis for the substrate specificity, bGalE 
has the saccharide binding pocket for catalyzing N-acetylated sugar or non-acetylated sugar similar to 
substrate binding of hGalE, which is the result of the evolution for utilizing various oligosaccharides in 
the human gastrointestinal tract, where common mono-and disaccharides are insufficient. 
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Table 3-4 A survey for the structure of GalE enzymes up to date. 
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Chapter 4 Concluding Remarks 
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 The studies of metabolism are basic for understanding life sciences. Sugar metabolic pathways, one 
of major metabolisms, are essential for life. The sugar metabolic pathways are based on sequential 
actions of various enzymes, such as hydrolases, oxidoreductases, transferases, lyases, or isomerases. 
The researches of functional and structural features for novel enzymes contribute to understand reaction 
mechanisms and to discover new sugar metabolic pathways. In this study, I study enzymes in two novel 
alternative sugar metabolic pathways from microbes; intracellular pathways linked to oxidative 
cellulose degradation and bifidobacteral consumption of human milk oligo saccharides and intestinal 
mucin glycoproteins. These two novel pathways finally linked to the glycolysis pathway. However, 
CBAP and bGalE involved in these pathways had been still unknown about catalytic mechanism or the 
reasons why the enzymes have broad substrate specificity with a concrete structural basis. Therefore, 
X-ray crystallography and a mutational analysis of CBAP and bGalE were performed to study their 
reaction mechanism, the catalytic residues, and substrate specificity. 
 In chapter 2, X-ray crystallography was performed on CBAP from S. degradans with the 
selenomethionine-SAD phasing method. CBAP catalyzes reversible phosphorolysis of CbA or Glc-
β1,3-GlcUA. To analyze the catalytic mechanism, crystal structures of CBAP in complex with Apo, 
CbA, GlcA, and Glc-β1,3-GlcUA was determined. In the CbA complex, the glucose and the GlcA 
moietes of CbA are bound at subsite -1 and +1, respectively, exhibiting a catalytically plausible structure 
for the phosphorolytic reaction. The C1 carboxyl group of the GlcA moiety of CbA interacts with R609 
and K613 at subsite +1. In the GlcA complex, a dehydrated compound LGC and GlcA are bound at 
subsite -1 and +1, respectively. The C1 carboxyl group of the GlcA interacts with R609, K613, and 
Q190', advocating that they are key residues for the molecular recognition of the aldonic acid. On the 
other hand, in the Glc-β1,3-GlcUA complex, the GlcUA moiety forms as a pyranose and binds at a 
displaced position. The C6 carboxyl group is not recognized by R609, K613, and Q190'. The 
conformation of Glc-β1,3-GlcUA was different from that of CbA at active site. To examine the 
importance of these residues on binding of the aldonic acid and the uronic acid, a mutational analysis 
was conducted. According to the result, R609, K613, and Q190' residues are required for both aldonic 
acid and uronic acid, indicating that Glc-β1,3-GlcUA complex was an artificial structure due to the high 
concentration of sulfate ion compared to the concentration of the disaccharide ligand used for the 
soaking experiment. Moreover, a possible binding model of GlcUA at subsite +1 elucidates that C6 
carboxyl group can be placed at the site surrounded by R609, K613, and Q190'. According to these 
results, I conclude that both CbA and Glc-β1,3-GlcUA are catalyzed by the CBAP in the same manner. 
The active site in CBAP was compared with those of GH94 enzymes, showing that CBAP has a unique 
subsite +1 in the aspect of substrate specificity. 
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 In chapter 3, X-ray crystallography was performed on GalE from B. longum for substrate specificity. 
The bGalE structure in complex with UDP, UDP-GlcNAc, and UDP-Glc was determined with 
molecular replacement. The overall structure can be roughly divided into an NAD+ binding N-terminal 
domain and an UDP-hexose binding C-terminal domain. The structure of bGalE is typical Rossmann 
fold composed of a seven-strand parallel β-sheet flanked by nine α-helices. The cofactor NAD+ was 
intrinsically bound to all complexes. The nicotinamide ring of NAD+ in all complexes forms an oxidized 
form adopting syn conformation. In structural superimposition between UDP-GlcNAc and UDP-Glc 
complex, the orientation of side chain of Asn200 at the UDP-hexose binding site was different; it swings 
“in” and “out” in the complex structures with UDP-Glc and UDP-GlcNAc, respectively. In both 
complexes, C4 of UDP-GlcNAc/UDP-Glc was positioned at 3.2 Å and 3.4 Å from C4 of the 
nicotinamide ring, respectively, indicating that C4 hydroxyl group of UDP-hexose transfers the C4 
hydride to cofactor. According to the superimposition of substrate binding pocket in represented group 
1, 2, and 3 enzymes, Asn200 in bGalE and Asn207 in hGalE move “swing in” or “swing out” depending 
on binding of N-acetylated or non-acetylated sugars. On the other hand, Asn199 in eGalE was fixed to 
be “swing in” and bulky Tyr299 side chain makes the substrate binding pocket narrower compared to 
Cys299 in bGalE. In comparison between bGalE and WbpP at the active site, even though, Ala209 in 
WbpP has the same orientation with Asn200 in bGalE, it does not show any “swing in or swing out”. 
The movement of Asn in group 2 is significant for recognizing and binding N-acetylated or non-
acetylated sugars. For better understanding for substrate specificity, a conceptual model originally 
proposed by Ishiyama et al. (10) was extended to bGalE. As a result, the configuration of six walls in 
bGalE are similar to that in hGalE. Therefore, bGalE was shown to allow N-acetylated or non-acetylated 
sugars to accommodate in substrate binding pocket with a concrete structural basis. 
 In this study, I determined the crystal structures of CBAP and bGalE involved in novel sugar metabolic 
pathways. According to the structural analysis, these enzymes have been shown to be specialized for 
their substrates through evolution. CBAP has a unique subsite +1 compared to GH94 emzymes, and 
bGalE has a broad substrate specificity competed with homologous GalE enzymes. This is because 
organisms in specialized environments sometimes face to live or survive. Therefore, they have to 
modify their enzymes to utilize substances in the environment. Studies of these two sugar metabolic 
enzymes also provide beneficial tools in the investigations of relationship between structure and 
function of enzyems for oligosaccharide synthesis, and for wide range of applications in biomass 
utilization and development of novel functional food for human health. 
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